← FDA Drug Approvals (Drugs@FDA)
LORATADINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2021-05-07
Drug application
- FDA Application #
ANDA210409- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LORATADINE
- Generic name
- LORATADINE
- Active ingredients
- LORATADINE
- Dosage form
- SYRUP
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- HETERO LABS LTD III
- Manufacturer
- Camber Consumer Care Inc
- First approval
- 2021-05-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown